StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a report released on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners assumed coverage on shares of Aptevo Therapeutics in a report on Monday, October 9th. They issued a buy rating for the […]
StockNews.com started coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners assumed coverage on shares of Aptevo Therapeutics in a report on Monday, October 9th. They issued a buy rating on […]
StockNews.com started coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a report published on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners assumed coverage on shares of Aptevo Therapeutics in a research report on Monday, October 9th. They set a buy rating for […]
StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners began coverage on shares of Aptevo Therapeutics in a research note on Monday, October 9th. They issued a […]
StockNews.com started coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) in a research note published on Friday. The firm issued a hold rating on the biotechnology company’s stock. Separately, Alliance Global Partners assumed coverage on shares of Aptevo Therapeutics in a research note on Monday, October 9th. They issued a buy rating on […]